NCT04055142 2024-07-10
TreatAIN
Hospital Universitari Vall d'Hebron Research Institute
Phase 3 Completed
Clinical Trials
10 trialsNCT02567149 2017-07-02
Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.
University of Minnesota
Phase 2 Withdrawn
NCT02976987 2016-11-30
A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.
Brugmann University Hospital
Phase 2 Completed
NCT01946009 2016-06-29
CIDAN12
Fundacion SEIMC-GESIDA
Phase NA Completed
NCT02515877 2016-06-09
HPV-RX
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Completed
NCT00550589 2015-12-21
Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus
AIDS Malignancy Consortium
Phase 2 Completed
NCT00019240 2013-06-20
Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
National Cancer Institute (NCI)
Phase 2 Completed
NCT00001126 2010-08-27
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00811408 2010-01-28
Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00002327 2005-06-24
The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
NIH AIDS Clinical Trials Information Service
Phase 1 Completed